1989
DOI: 10.1016/0016-5085(89)90650-1
|View full text |Cite
|
Sign up to set email alerts
|

Dietary modification of chyle composition in chylothorax

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
34
0
7

Year Published

1992
1992
2015
2015

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 67 publications
(41 citation statements)
references
References 18 publications
0
34
0
7
Order By: Relevance
“…A low-fat diet with medium-chain triglycerides, which to the largest extent are absorbed directly into the blood, will cause the chyle to decrease in amount, but there will still be a flow [34]. The next step is total parenteral nutrition, which will diminish flow even further.…”
Section: Treatmentmentioning
confidence: 99%
“…A low-fat diet with medium-chain triglycerides, which to the largest extent are absorbed directly into the blood, will cause the chyle to decrease in amount, but there will still be a flow [34]. The next step is total parenteral nutrition, which will diminish flow even further.…”
Section: Treatmentmentioning
confidence: 99%
“…However, such a diet may induce severe malnutrition from deficiency of energy, liposoluble vitamins and essential (ω3 and ω6) fatty acids. Thus, an MCT diet is indicated to maintain energy intake and to limit lymph flow, even if not all MCTs are absorbed directly into the portal system [14].Oral or intravenous supplementation of ADEK vitamins and essential fatty acids is also recommended. In our cohort, all the children received an MCT diet, after transient TPN in 4 children.…”
Section: Discussionmentioning
confidence: 97%
“…Dietary interventions (low-fat diet, medium-chain triglyceride diet, total parenteral nutrition, etc) are commonly used, and may occasionally be effective, but are difficult for patients to maintain. [7][8][9][10] Surgical and percutaneous radiological interventions (eg, thoracic duct ligation/embolization, pleuroperitoneal shunting, chemical pleurodesis) may be effective but can be associated with morbidity and mortality. [11][12][13][14][15][16] Octreotide therapy has been used with variable efficacy in a predominantly pediatric population.…”
Section: Discussionmentioning
confidence: 99%